FDA Approved: REZLIDHIA — Original Application (Rigel Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Rezlidhia (olutasidenib) through an original application for adults with IDH1-mutant acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• REZLIDHIA (OLUTASIDENIB)

Snippet

ORIG AP for REZLIDHIA (OLUTASIDENIB)